China's drug regulator approved Zhejiang AngLiKang Pharmaceutical's (SHE:002940) rosuvastatin ezetimibe tablets, according to a Saturday filing with the Shenzhen bourse.
The drug contains rosuvastatin calcium and ezetimibe that help contain high cholesterol levels, among other uses.